Originally posted by ashc15
- VarmCosmo failure was primarily VarmCosmo's fault... I agree we could have done more due diligence but we didn't fail our side of the contract. This is well in the past and hopefully a learning curve for the business.
- Yes, we sold the loss making Derma arm to a private company. CannaGlobal controls whether they go public or private; not much we can about it. Note that the revenue from the raw material orders have already given us much more than we ever received from the Derma business. It also allowed us to purely focus on the Pharma side. I think this was a good decision.
- We have over $4m cash based on the most recent quarterly. Yes, most likely will need to do a future cap raise but revenue is growing fast and the LSE Listing is coming up. We are heading in the right direction.
- Salaries are actually fairly typical for similar sized companies and were actually less than the year before: https://**.st/stocks/au/pharmaceuti...maceuticals-limiteds-asxmxc-ceo-getting-paid/
- The new product range is not a separate company or owned by a separate company; you have been misguided here. This was never been stated in the article. The same way Powerade is a brand that is owned by Coca Cola Company; Mecury Pharma is a BRAND owned MXC. If all these products and revenue were owned by another company, we would not be announcing it for this company lol... It would also be illegal and a straight conflict of interest.
- I'm not sure why you are complaining about dilution and losses for a spec company. This is part of the building phase and MXC is a long term hold. If we achieve what we are working towards, it will pay off long term. However, it is always a risk. I completely understand why some investors choose not to take the risk.
Are you connected to the board members by any chance?
Casually slipping around the real facts and truth again. As I have said before, you're good lol
You are deliberately misleading and know it.
By the way, the deal to sell Derma cost more than they have got back from Cannaglobal at this stage. So Derma still lost the company money last yr. They haven't recouped what they supposedly paid for 49% off Burstein.
Can you explain why there is a company owned by Roby and Anthony Eastman in the same name as this new brand? Just a coincidence?
- Forums
- ASX - By Stock
- RGT
- Ann: Launch of New Product Line in Aus & NZ - Mercury Pharma
Ann: Launch of New Product Line in Aus & NZ - Mercury Pharma, page-54
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RGT (ASX) to my watchlist
(20min delay)
|
|||||
Last
56.5¢ |
Change
0.060(11.9%) |
Mkt cap ! $27.34M |
Open | High | Low | Value | Volume |
50.5¢ | 56.5¢ | 50.5¢ | $8.762K | 15.72K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 961 | 53.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
56.5¢ | 1389 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 961 | 0.530 |
2 | 4959 | 0.505 |
1 | 5950 | 0.500 |
1 | 1000 | 0.470 |
1 | 6000 | 0.400 |
Price($) | Vol. | No. |
---|---|---|
0.565 | 1389 | 1 |
0.570 | 223 | 1 |
0.575 | 650 | 1 |
0.650 | 45000 | 1 |
0.700 | 1368 | 1 |
Last trade - 14.14pm 08/10/2024 (20 minute delay) ? |
Featured News
RGT (ASX) Chart |